Make scientific figures in minutes
Create publication-quality figures with pre-made icons and templates, all from BioRender's web-based software
Use Icons In The App
Try a synonym, or sign up to request an icon from the app.
Cancer cell (3D, translucent)
[{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc5/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc5/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc4/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc4/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc3/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc3/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc2/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc2/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc1/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc1/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cc0/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cc0/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cbf/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cbf/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cbe/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cbe/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cbd/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cbd/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cbc/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cbc/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cbb/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cbb/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cba/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cba/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb9/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb9/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb8/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb8/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb7/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb7/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb6/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb6/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb5/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb5/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb4/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb4/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb3/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb3/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb2/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb2/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb1/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb1/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cb0/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cb0/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590caf/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590caf/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cae/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cae/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cad/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cad/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cac/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cac/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590cab/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590cab/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590caa/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590caa/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca9/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca9/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca8/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca8/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca7/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca7/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca6/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca6/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca5/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca5/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca4/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca4/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca3/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca3/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca2/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca2/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca1/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca1/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590ca0/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590ca0/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9f/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9f/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9e/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9e/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9d/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9d/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9c/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9c/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9b/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9b/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c9a/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c9a/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c99/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c99/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c98/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c98/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c97/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c97/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c96/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c96/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c95/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c95/6048e0be5b85360028590c93.png"},{"image":"https://icons.cdn.biorender.com/w75xh75/6048e15c5b85360028590c94/6048e0be5b85360028590c93.png","waterMarkImage":"https://icons.cdn.biorender.com/w550xh620/6048e15c5b85360028590c94/6048e0be5b85360028590c93.png"}]
Use this icon in BioRender along with 1000s of others to make your next science figure in minutes
.png)
SIGN UP FREEKeywords
popular icons,cancer cell,cancer,tumor cell,cancerous oncological,oncology,metastatic,metastasis,abnormal,carcinoma,leukaemia,leukemia,lymphoma,sarcoma,myeloma,three-dimensional,3d,3-d,cancer,tumor,3d cancer cell
Image types
BioRender icons and templates meet journal, grant, and copyright standards. For AI-generated figures, policies vary. Learn More
Related Categories
Join 1,500,000 other scientists on BioRender
Sign up for your free account and start creating scientific figures faster today
FAQs
What is BioRender?
Can I use this icon in a BioRender figure or scientific illustration?
